XML 44 R33.htm IDEA: XBRL DOCUMENT v3.25.1
Correction of Errors in Previously Reported Consolidated Financial Statements - Schedule of Restatement on the Condensed Consolidated and Combined Statement of Cash Flows (Details) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Cash Flows From Operating Activities:      
Net income (loss) $ 9,194,630 $ (32,535,982) $ 25,929,003
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
Depreciation and amortization 69,942 94,392  
Stock based compensation 754,361 1,359,000  
Equity compensation expense 671  
Non-cash interest expense 90,450  
Change in fair value of derivative liabilities (12,417,450) 8,182,500 $ 18,011,100
Issuance of common stock and warrants 20,590,717  
As Reported [Member]      
Cash Flows From Operating Activities:      
Net income (loss)   (29,766,263)  
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
Depreciation and amortization   94,392  
Stock based compensation   1,359,000  
Equity compensation expense    
Non-cash interest expense    
Change in fair value of derivative liabilities   8,182,500  
Issuance of common stock and warrants   17,820,998  
Adjustments [Member]      
Cash Flows From Operating Activities:      
Net income (loss)   (2,769,719)  
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
Depreciation and amortization    
Stock based compensation    
Equity compensation expense    
Non-cash interest expense    
Change in fair value of derivative liabilities    
Issuance of common stock and warrants   $ 2,769,719